» Articles » PMID: 29651899

Caffeine Does Not Affect Susceptibility to Cortical Spreading Depolarization in Mice

Abstract

Several factors that modulate migraine, a common primary headache disorder, also affect susceptibility to cortical spreading depolarization (CSD). CSD is a wave of neuronal and glial depolarization and thought to underlie the migraine aura and possibly headache. Here, we tested whether caffeine, known to alleviate or trigger headache after acute exposure or chronic use/withdrawal, respectively, modulates CSD. We injected C57BL/6J mice with caffeine (30, 60, or 120 mg/kg; i.p.) once ( acute) or twice per day for one or two weeks ( chronic). Susceptibility to CSD was evaluated by measuring the electrical CSD threshold and by assessing KCl-induced CSD. Simultaneous laser Doppler flowmetry was used to assess CSD-induced cortical blood flow changes. Recordings were performed 15 min after caffeine/vehicle administration, or 24 h after the last dose of chronic caffeine in the withdrawal group. The latter paradigm was also tested in mice carrying the familial hemiplegic migraine type 1 R192Q missense mutation, considered a valid migraine model. Neither acute/chronic administration nor withdrawal of caffeine affected CSD susceptibility or related cortical blood flow changes, either in WT or R192Q mice. Hence, adverse or beneficial effects of caffeine on headache seem unrelated to CSD pathophysiology, consistent with the non-migrainous clinical presentation of caffeine-related headache.

Citing Articles

Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Borkum J Neurochem Res. 2021; 46(8):1913-1932.

PMID: 33939061 DOI: 10.1007/s11064-021-03335-9.


An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine.

Levine A, Vanderah T, Largent-Milnes T Cephalalgia. 2020; 41(3):404-416.

PMID: 33131303 PMC: 10443224. DOI: 10.1177/0333102420966984.


Sudden Caffeine Withdrawal Triggers Migraine-A Randomized Controlled Trial.

Alstadhaug K, Ofte H, Muller K, Andreou A Front Neurol. 2020; 11:1002.

PMID: 33013662 PMC: 7512113. DOI: 10.3389/fneur.2020.01002.


The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment.

Nowaczewska M, Wicinski M, Kazmierczak W Nutrients. 2020; 12(8).

PMID: 32731623 PMC: 7468766. DOI: 10.3390/nu12082259.


Optimized mouse model of embolic MCAO: From cerebral blood flow to neurological outcomes.

Wang R, Wang H, Liu Y, Chen D, Wang Y, Rocha M J Cereb Blood Flow Metab. 2020; 42(3):495-509.

PMID: 32312170 PMC: 8985433. DOI: 10.1177/0271678X20917625.


References
1.
Moskowitz M, Nozaki K, Kraig R . Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993; 13(3):1167-77. PMC: 2737353. View

2.
Deboer T, van Diepen H, Ferrari M, van den Maagdenberg A, Meijer J . Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice. Sleep. 2013; 36(1):127-36. PMC: 3524534. DOI: 10.5665/sleep.2316. View

3.
Conlay L, Conant J, deBros F, Wurtman R . Caffeine alters plasma adenosine levels. Nature. 1997; 389(6647):136. DOI: 10.1038/38160. View

4.
Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz M . Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006; 59(4):652-61. DOI: 10.1002/ana.20778. View

5.
Hering-Hanit R, Gadoth N . Caffeine-induced headache in children and adolescents. Cephalalgia. 2003; 23(5):332-5. DOI: 10.1046/j.1468-2982.2003.00576.x. View